Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Prospective Cohort Study

Background: Impaired immune responses to COVID-19 vaccines have been observed in autoimmune rheumatic disease patients. Determining the most effective and safe vaccine regimen is critically needed in such a population. We aim to compare the immunogenicity and safety of three COVID-19 vaccine regimen...

Descripción completa

Detalles Bibliográficos
Autores principales: Assawasaksakul, Theerada, Lertussavavivat, Tanat, Sathitratanacheewin, Seelwan, Oudomying, Nont, Vichaiwattana, Preeyaporn, Wanlapakorn, Nasamon, Poovorawan, Yong, Avihingsanon, Yingyos, Assawasaksakul, Nawaporn, Buranapraditkun, Supranee, Kittanamongkolchai, Wonngarm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227480/
https://www.ncbi.nlm.nih.gov/pubmed/35746461
http://dx.doi.org/10.3390/vaccines10060853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227480/
https://www.ncbi.nlm.nih.gov/pubmed/35746461
http://dx.doi.org/10.3390/vaccines10060853

Ejemplares similares